Patient Journey as a key to develop Inhalation combination products
May 12, 2021Read moreThe latest issue of ‘Pharma Technology’ is highlighted our experts point of view about developing adapted inhalation device for a better patient’s adherence.
Nemera is excited to announce that its multidose eye dropper Novelia® has been approved in Brazil!
May 5, 2021Read moreNovelia, Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations
The pivotal role played by device developers to improve patient eye care
April 22, 2021Read moreThe latest issue of ‘Ophthalmic Drug Delivery’ is highlighted our experts discussion about the challenges of glaucoma and dry eyes patient face with eye drop administration.
Nemera: The Holistic Partner for Your Combination Product Development
April 19, 2021Read moreThe latest issue of ‘IPI magazine’ is highlighted Nemera as a holistic partner for your combination product development
Marc Hämel’s insights in MassMEDIC’s annual DDD report
March 25, 2021Read moreRead our CEO interview in the MassMedic in partnership with Alira Health
